Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Open accessAbstract
T cell differentiation into distinct functional effector and inhibitory subsets is regulated, in part, by the cytokine environment present at the time of antigen recognition. Here, we show that hypoxia-inducible factor 1 (HIF-1), a key metabolic sensor, regulates the balance between regulatory T cell (T(reg)) and T(H)17 differentiation. HIF-1 enhances T(H)17 development through direct transcriptional activation of RORγt and via tertiary complex formation with RORγt and p300 recruitment to the IL-17 promoter, thereby regulating T(H)17 signature genes. Concurrently, HIF-1 attenuates T(reg) development by binding Foxp3 and targeting it for proteasomal degradation. Importantly, this regulation occurs under both normoxic and hypoxic conditions. Mice with HIF-1α-deficient T cells are resistant to induction of T(H)17-dependent experimental autoimmune encephalitis associated with diminished T(H)17 and increased T(reg) cells. These findings highlight the importance of metabolic cues in T cell fate determination and suggest that metabolic modulation could ameliorate certain T cell-based immune pathologies.
AI snapshot
Written from the paper’s full text.
TL;DR
HIF-1α promotes TH17 differentiation by directly activating RORγt and cooperating with RORγt/p300 at IL-17A, while simultaneously attenuating Treg differentiation by targeting Foxp3 for proteasomal degradation. Mice with HIF-1α-deficient T cells are resistant to TH17-dependent EAE and show diminished TH17 and increased Treg responses.
Key findings
- HIF-1α expression is induced under TH17-skewing conditions in a Stat3-dependent manner; HIF-1α−/− T cells show minimal induction of IL-17A and RORγt transcripts and reduced IL-17A+ cells, with a dramatic increase in Foxp3+ cells.
- HIF-1α directly transactivates RORγt through a conserved HRE. RORγt overexpression induced IL-17A in 45.7% of HIF-1α+/+ T cells versus 0.72% with control retrovirus, but only 1.33% in HIF-1α−/− T cells. HIF-1α, RORγt, and p300 co-localize at IL-17A, IL-17F, and IL-23R promoters; triple co-expression increased IL-17A reporter activity more than 10-fold over any two factors, and hypoxia further enhanced IL-17A production.
- HIF-1α binds Foxp3 and mediates its ubiquitination and proteasomal degradation without changing Foxp3 mRNA; HIF-1α−/− T cells have higher Foxp3 protein under both TH17- and Treg-skewing conditions, and hypoxia decreases Foxp3+ cells. Degradation is blocked by proteasome inhibition and requires PHD2/proline hydroxylation of HIF-1α.
- In EAE, WT mice developed disease while T-HIF-1α−/− mice were highly resistant; at peak disease, WT lymph node, spleen, and CNS CD4+ T cells had higher IL-17+ proportions, and at day 21 T-HIF-1α−/− mice showed increased Foxp3+ and decreased IL-17+ CD4+ cells.
Methods
- Mice included T cell-specific HIF-1α knockout (CD4cre × HIF-1αflox/flox, T-HIF-1−/−), WT, Foxp3-GFP, and Rorc−/− mice. Naïve T cells were sorted and cultured under TH17, Treg, TH1, or TH2 conditions; hypoxia experiments used 1% O2.
- Molecular analyses included qRT-PCR, ChIP, luciferase reporter assays, co-immunoprecipitation, GST pull-down, Western blotting, and ubiquitination assays. EAE was induced with MOG35–55 in CFA plus pertussis toxin, with daily disease scoring.
- Statistical significance was determined by unpaired Student’s t test (*p<0.05).
Limitations
- The paper states that future studies are needed to delineate precisely how HIF-1α protein turnover dynamics in T cells modulate Foxp3 levels.
- The paper discusses a discrepancy with prior work suggesting HIF-1α is a general negative regulator of T cell activation, arguing that those experiments did not evaluate specific T cell differentiation decisions.
- Evident from the text: much of the mechanistic dissection relies on overexpression in Jurkat/293T cells and reporter assays, and the in vivo validation is limited to the MOG35–55 EAE model; no human data are presented.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 33 cited sources checked · 0 supported · 0 flagged
- Findingown data
The hypoxia-induced increase in IL-17A+ cells is abrogated in HIF-1α−/− T cells.
“This increase was abrogated in HIF-1α −/− T cells (Figure 2D and S2E)”
Quote in the paperSubstantial claim - Findingown data
IL-17A+ cell population is significantly increased upon overexpression of HIF-1α under TH17 skewing conditions.
“The IL-17A+ cell population was also significantly increased upon overexpression of HIF-1α under TH17 skewing conditions (Figure 2C, right panel).”
Quote in the paperSubstantial claim - Findingown data
Increasing amounts of HIF-1α plasmid cause corresponding increases in RORγt promoter activity, particularly upon PMA and ionomycin stimulation.
“Transfection of Jurkat cells with the RORγt promoter-driven reporter construct, together with increasing amounts of HIF-1α plasmid indeed caused corresponding increases in RORγt promoter activity, particularly upon PMA and ionomycin stimulation (Figure S3C).”
Quote in the paperSubstantial claim - Findingown data
mRNA expression of IL-17F and IL-23R is much lower in HIF-1α−/− T cells than WT T cells.
“The mRNA expression of other TH17-related genes such as IL-17F and IL-23R was also much lower in HIF-1α −/− T cells than WT T cells”
Quote in the paperSubstantial claim - Findingown data
Under TH17-skewing, a higher proportion of IL-17A+ cells is observed in hypoxic compared to normoxic culture conditions.
“after TH17-skewing we observed a higher proportion of IL-17A+ cells in hypoxic compared to normoxic culture conditions.”
Quote in the paperSubstantial claim
- Findingown data
Stat3-deficient T cells cultured under TH17 skewing conditions for 4 days have very little HIF-1α protein detected by Western blot.
“after isolating CD4+CD62LhighCD25-(naïve) Stat3-deficient T cells from CD4-cre x Stat3flox/flox mice and culturing them under TH17 skewing conditions for 4 days, very little HIF-1α protein was detected by Western blot (Figure 1E).”
Quote in the paperSubstantial claim - Findingown data
No significant differences in IFN-γ or IL-4 are seen between WT and HIF-1α−/− T cells under TH1 or TH2 skewing conditions.
“no significant differences in IFN-γ or IL-4 were seen between WT and HIF-1α−/− T cells under TH1 or TH2 skewing conditions (Figure S2A)”
Quote in the paperSubstantial claim - Findingown data
HIF-1α−/− T cells cultured under TH17 conditions display a marked reduction in IL-17A+ cells.
“these HIF-1 deficient T cells displayed a marked reduction in IL-17A+ cells.”
Quote in the paperSubstantial claim - Findingown data
HIF-1α activates the human RORγt promoter similarly to the mouse.
“Luciferase assays using the human sequence demonstrated that HIF-1α activates this promoter in a similar fashion to that of the mouse (Figure S3D and S3E).”
Quote in the paperNot a substantial claim - Findingown data
CD4+ cells from WT and HIF-1α−/− groups show comparable proliferative capacity.
“CD4+ cells from both groups showed comparable proliferative capacity (Figure S2B).”
Quote in the paperSubstantial claim - Findingown data
T-HIF-1−/− mice have normal development of CD4+ and CD8+ T cells, B cells and dendritic cells.
“T-HIF-1−/− mice had normal development of CD4+ and CD8+ T cells, B cells and dendritic cells (Figure S1).”
Quote in the paperNot a substantial claim - Findingown data
A HIF-1α mutant lacking the DNA binding domain fails to activate the wild type RORγt promoter.
“the expression of a HIF-1α mutant gene lacking the DNA binding domain failed to activate the wild type RORγt promoter (Figure 3B).”
Quote in the paperSubstantial claim - Findingown data
WT T cells stimulated with TGF-β and IL-6 show significant induction of IL-17A protein.
“We observed significant induction of IL-17A protein by WT T cells stimulated with TGF-β and IL-6 (Figure 2A).”
Quote in the paperSubstantial claim - Findingown data
Ectopic expression of HIF-1α substantially increases the percentage of IL-17A+ cells even in the absence of IL-6 and TGF-β.
“The ectopic expression of HIF-1α substantially increased the percentage of IL-17A+ cells even in the absence of the TH17-driving cytokines IL-6 and TGF-β (Figure 2C).”
Quote in the paperSubstantial claim - Findingown data
HIF-1α overexpression-induced IL-17A is associated with upregulation of RORγt mRNA and protein.
“This induction of IL-17A was associated with the upregulation of both RORγt mRNA and protein (Figure S2).”
Quote in the paperSubstantial claim - Findingown data
Mutated HIF-1α binding sites in the RORγt promoter have much lower luciferase activity compared to wild type RORγt promoter.
“The mutated constructs had much lower luciferase activity compared to that of a wild type RORγt promoter-driven luciferase reporter (Figure 3A).”
Quote in the paperSubstantial claim - Findingown data
HIF-1α−/− T cells show a dramatic increase in proportion of Foxp3+ cells.
“we also noted a dramatic increase in the proportion of Foxp3+ cells in HIF-1α −/− T cells (Figure 2A).”
Quote in the paperSubstantial claim - Findingown data
Recruitment of HIF-1α to these regions is dependent on RORγt since it is abrogated in T cells from RORγt knockout mice.
“This recruitment of HIF-1α was dependent on RORγt since it was abrogated in T cells from RORγt knockout mice (Figure S5A–D).”
Quote in the paperSubstantial claim - Findingown data
GST-HIF-1α (amino acids 1-80), but not GST alone, binds RORγt.
“GST-HIF-1α (amino acids1–80), rather than GST alone, was bound to RORγt (Figure S4F).”
Quote in the paperSubstantial claim - Findingown data
HIF-1α and Foxp3 physically interact in co-transfected 293T cells.
“Immunoprecipitation and Western blot analysis of 293 T cells co-transfected with HIF-1α and Foxp3, in fact, demonstrated a physical interaction between these two molecules (Figure S7A).”
Quote in the paperSubstantial claim - Findingown data
Expression of wild type HIF-1α in the presence of RORγt results in significantly increased IL-17 promoter reporter activity over that induced by RORγt alone.
“The expression of wild type HIF-1α in the presence of RORγt resulted in significantly increased reporter gene activity over that induced by RORγt alone (Figure 4A).”
Quote in the paperSubstantial claim - Findingown data
Foxp3+ cells are significantly decreased under hypoxic conditions relative to normoxia when T cells are cultured with TGF-β and IL-2.
“T cells were thus cultured with TGF-β and IL-2 under hypoxic conditions. Foxp3+ cells were significantly decreased under these hypoxic conditions relative to normoxia (Figure 5D).”
Quote in the paperSubstantial claim - Findingown data
Foxp3 mRNA levels in WT and HIF-1α−/− T cells stimulated under TH17 skewing conditions are essentially identical.
“Foxp3 mRNA levels in WT and HIF-1α −/− T cells stimulated under TH17 skewing conditions were essentially identical (Figure 5A).”
Quote in the paperSubstantial claim - Findingown data
HIF-1α enhances TH17 development.
“HIF-1α enhances TH17 development through direct transcriptional activation of RORvt, and via tertiary complex formation with RORvt and p300 recruitment to the IL17 promoter, thereby regulating TH17 signature genes.”
Quote in the paperSubstantial claim - Findingcitation
A HIF-1α mutant with a C-terminal deletion of the p300 binding domain fails to synergize with RORγt and p300 in activation of the IL-17A promoter.
“a HIF-1α mutant with a C-terminal deletion of the p300 binding domain (Arany et al., 1996) failed to synergize with RORγt and p300 in the activation of the IL-17A promoter”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Arany et al., 1996 source
Not checked in the free run.
- Findingown data
Mice with HIF-1α deficient T cells are resistant to induction of TH17-dependent experimental autoimmune encephalitis associated with diminished TH17 and increased Treg cells.
“Mice with HIF-1α deficient T cells are resistant to induction of TH17-dependent experimental autoimmune encephalitis associated with diminished TH17 and increased Treg cells.”
Quote in the paperSubstantial claim - Findingown data
The HIF-1α binding domain on Foxp3 maps to the C-terminus of Foxp3.
“The HIF-1α binding domain was further mapped to the C-terminus of Foxp3 (Figure S7B)”
Quote in the paperNot a substantial claim - Findingown data
HIF-1α is recruited to several other putative RORγt binding regions, including CNS2.
“ChIP analysis revealed that HIF-1α was recruited to several other putative RORγt binding regions, including CNS2.”
Quote in the paperSubstantial claim - Findingown data
In T-HIF-1−/− mice, steady-state levels of Foxp3+ cells in the lamina propria of the gut are significantly increased compared to controls.
“steady state levels of Foxp3+ cells in the lamina propria of the gut, which, as indicated above (Koch, 2002), is relatively hypoxic, are significantly increased in T-HIF-1−/− mice (Figure S6A–D).”
Quote in the paperSubstantial claim - Findingown data
This binding is specific since no significant signal is detected at a non-RORγt binding region within the IL-17A promoter.
“This binding, as analyzed by ChIP, was specific since no significant signal could be detected at a non-RORγt binding region within the IL-17A promoter.”
Quote in the paperSubstantial claim - Findingown data
In HIF-1α+/+ T cells, retroviral RORγt expression induces a significantly higher proportion of IL-17A+ cells (45.7%) under non-skewing conditions compared to control retrovirus recipients (0.72%).
“In HIF-1α+/+ T cells, retroviral RORγt expression induced a significantly higher proportion of IL-17A+ cells (45.7%) under non-skewing conditions, compared to control retrovirus recipients (0.72%) (Figure 3D and 3E, left panels).”
Quote in the paperSubstantial claim - Findingown data
Ectopic RORγt expression in HIF-1α−/− T cells induces a strikingly diminished population of IL-17A+ cells (1.33%).
“However, ectopic RORγt expression in HIF-1α−/− T cells induced a strikingly diminished population of IL-17A+ cells (1.33%) (Figure 3E, right panel).”
Quote in the paperSubstantial claim - Findingown data
Only GST fusions of the HIF-1α N-terminus (1-80 aa), but not GST alone or other HIF-1α fragments, successfully pull down RORγt.
“Only GST fusions of the HIF-1α N-terminus (1–80 aa), but not GST alone or other HIF-1α fragments, successfully pulled down RORγt (Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
Histones H3 and H4 around the IL-17A promoter region are highly acetylated in WT compared to HIF-1−/− T cells under TH17-inducing conditions.
“ChIP assays revealed that histones H3 and H4 around the IL-17A promoter region were highly acetylated in WT compared to HIF-1−/−T cells under TH17-inducing conditions (Figure 4G).”
Quote in the paperSubstantial claim - Findingcitation
A HIF-1α mutant with a characterized DNA binding domain deletion shows no defect in inducing reporter gene activity.
“a HIF-1α mutant with a characterized DNA binding domain deletion (Arany et al., 1996) showed no defect in inducing reporter gene activity”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Arany et al., 1996 source
Not checked in the free run.
- Findingown data
Wild type p300, but not Δp300, can synergistically enhance IL-17A promoter activity in the presence of HIF-1α and RORγt.
“Wild type p300, but not Δp300 could synergistically enhance IL-17A promoter activity in the presence of HIF-1α and RORγt (Figure S5E).”
Quote in the paperSubstantial claim - Findingown data
Endogenous HIF-1α and Foxp3 physically interact in iTreg cells.
“This interaction between HIF-1α and Foxp3 was further confirmed by endogenous co-IP in iTreg cells (Figure 5E).”
Quote in the paperSubstantial claim - Findingown data
Under steady state conditions, T-HIF-1−/− mice have reduced proportions of IL-17A+ cells in the lamina propria.
“We found that, under steady state conditions, T-HIF-1−/− mice had reduced proportions of IL-17A+ cells in the lamina propria (Figure S6A–D)”
Quote in the paperSubstantial claim - Findingown data
HIF-1α−/− T cells cultured under Treg skewing conditions (TGF-β plus IL-2) express substantially more Foxp3 than WT T cells.
“HIF-1α −/− T cells cultured under Treg conditions also expressed substantially more Foxp3 than did WT T cells (Figure 5B and 5C).”
Quote in the paperSubstantial claim - Findingnone given
This regulation occurs under both normoxic and hypoxic conditions.
“Importantly this regulation occurs under both normoxic and hypoxic conditions.”
Quote in the paperSubstantial claim - Findingown data
Similar co-localized binding of RORγt, HIF-1α and p300 occurs at the promoters of IL-17F and IL-23R.
“we observed similar co-localized binding of RORγt, HIF-1α and p300 at the promoters of the TH17 signature genes IL-17F and IL-23R (Figure 4E).”
Quote in the paperSubstantial claim - Findingcitation
A HIF-1α mutant with a deletion in its p300 binding domain fails to activate the IL-17A promoter.
“Furthermore, a HIF-1α mutant with a deletion in its p300 binding domain (Arany et al., 1996) fails to activate the IL-17A promoter.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Arany et al., 1996 source
Not checked in the free run.
- Findingown data
RORγt, HIF-1α and p300 bind to the IL-17A promoter during TH17 differentiation.
“we detected localized binding of RORγt, HIF-1α and p300 to the IL-17A promoter determined using primers flanking the RORγt-binding site located at the IL-17A promoter region (Figure 4D).”
- Also stated in: § Abstract · plain
“HIF-1α enhances TH17 development through direct transcriptional activation of RORvt, and via tertiary complex formation with RORvt and p300 recruitment to the IL17 promoter, thereby regulating TH17 signature genes.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
HIF-1α co-immunoprecipitates with RORγt when Flag-tagged HIF-1α and Myc-tagged RORγt are co-expressed in Jurkat T cells.
“HIF-1α was found to co-immunoprecipitate (co-IP) with RORγt (Figure S4E).”
Quote in the paperSubstantial claim - Findingown data
Hyper-acetylated histones H3 and H4 are associated with the promoters of TH17 signature genes IL-17F and IL-23R in WT, but not in HIF-1α−/−, TH17 cells.
“Similarly, hyper-acetylated histones H3 and H4 were associated with the promoter of TH17 signature genes IL-17F and IL-23R in WT, but not in HIF-1α −/−, TH17 cells (Figure S6E and S6F).”
Quote in the paperSubstantial claim - Findingown data
IL-17A production in Jurkat T cells co-transfected with RORγt, HIF-1α and p300 is further increased under hypoxic conditions.
“IL-17A production in Jurkat T cells co-transfected with RORγt, HIF-1α and p300 was further increased under hypoxic conditions (Figure 4F).”
Quote in the paperSubstantial claim - Findingown data
Endogenous HIF-1α and RORγt co-immunoprecipitate in T cells cultured under TH17-skewing conditions.
“The association between HIF-1α and RORyt was further confirmed by co-IP of endogenous HIF-1α and RORyt in T cells cultured under TH17-skewing conditions (Figure 4B).”
Quote in the paperSubstantial claim - Findingown data
TH17 differentiation is enhanced under hypoxia in a HIF-1α-dependent manner.
“we found that TH17 differentiation is enhanced under hypoxia in a HIF-1α-dependent manner.”
Quote in the paperSubstantial claim - Findingown data
RORγt protein levels remain unchanged upon co-transfection with HIF-1α in 293T cells.
“RORγt protein levels remained unchanged upon co-transfection with HIF-1α (Figure S7D).”
Quote in the paperNot a substantial claim - Findingown data
At peak disease, WT mice have higher proportions of IL-17+ CD4+ T cells in lymph node, spleen, and CNS than T-HIF-1α−/− mice.
“At peak disease, lymph node-, spleen- and central nervous system (CNS)-infiltrating CD4+ T cells from WT mice contained higher proportions of IL-17+ cells compared to those of T-HIF-1α −/− mice (Figure 6B and 6C).”
Quote in the paperSubstantial claim - Findingnone given
HIF-1α protein is readily detectable in TH17 cells under normoxia.
“HIF-1α protein is readily detectable in TH17 cells under normoxia”
Quote in the paperSubstantial claim - Findingown data
T-HIF-1α−/− mice are highly resistant to MOG35-55-induced EAE compared to WT mice.
“WT mice immunized with MOG35–55 developed EAE, while T-HIF-1α −/− mice were highly resistant (Figure 6A).”
- Also stated in: § DISCUSSION · boosted
“Our in vivo findings demonstrate that mice with HIF-1α−/− T cells are resistant to induction of EAE, a TH17-dependent disease whose remission is dependent upon Treg cells (Schraml et al., 2009).”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · boosted
- Findingown data
Under normoxia, TH17 differentiation is significantly impaired without HIF-1α.
“the experiments utilizing HIF-1α−/− T cells confirm that under such conditions TH17 differentiation is significantly impaired without HIF-1α.”
Quote in the paperSubstantial claim - Findingown data
Hypoxic culture significantly enhances Foxp3 degradation in primary iTregs.
“Hypoxic culture significantly enhanced both Foxp3 ubiquitination and degradation in these cells (Figure 5I and 5J).”
Quote in the paperSubstantial claim - Findingown data
HIF-1α-mediated Foxp3 degradation is completely inhibited by a proteasome inhibitor.
“HIF-1α mediated Foxp3 degradation was completely inhibited in the presence of a proteasome inhibitor (Figure S8B).”
Quote in the paperSubstantial claim - Findingown data
Hypoxic culture significantly enhances Foxp3 ubiquitination in primary iTregs.
“Hypoxic culture significantly enhanced both Foxp3 ubiquitination and degradation in these cells (Figure 5I and 5J).”
Quote in the paperSubstantial claim - Findingown data
MG132 prevents ubiquitin-mediated Foxp3 degradation in iTreg cells under hypoxia.
“this ubiquitin-mediated Foxp3 degradation process could be prevented by addition of the proteasomal inhibitor MG132 to iTreg cells under hypoxia.”
Quote in the paperSubstantial claim - Findingown data
During the recovery phase of EAE, T-HIF-1−/− mice show a decrease in the proportion of IL-17+ CD4+ cells.
“T-HIF-1−/− mice showed a significant increase in the percentage of CD4+ Foxp3+ cells during the recovery phase of disease (21 days post-injection), concomitant with a decrease in the proportion of IL-17+ CD4+ cells in T-HIF-1−/−animals (Figure 6D and 6E).”
Quote in the paperSubstantial claim - Findingown data
The Foxp3 binding domain in HIF-1α is within the N-terminal 80 amino acids.
“the Foxp3 binding domain in HIF-1α was found to be within the N-terminal 80 amino acids by GST pull-down experiments (Figure S7C).”
Quote in the paperNot a substantial claim - Findingown data
Knockdown of PHD2 with siRNA eliminates the ability of wild-type HIF-1α to mediate Foxp3 degradation.
“Knockdown of PHD2 with siRNA also eliminated the ability of wild type HIF-1α to mediate the degradation of Foxp3 (Figure S8A).”
Quote in the paperSubstantial claim - Findingown data
A non-proline hydroxylatable HIF-1α (CA5-HIF-1α) is incapable of mediating Foxp3 degradation.
“Similar co-transfection assays using a HIF-1α plasmid containing an oxygen dependent domain (ODD) deletion (CA5-HIF-1α) further demonstrated that a non-proline hydroxylatable HIF-1α was incapable of mediating Foxp3 degradation (Figure 5G and 5H).”
Quote in the paperSubstantial claim - Findingown data
A HIF-1α mutant with prolines 402 and 564 mutated to alanines fails to induce Foxp3 degradation.
“The expression of P402A and P564A HIF-1α failed to induce Foxp3 degradation (Figure 5G and 5H).”
Quote in the paperSubstantial claim - Findingown data
During the recovery phase of EAE (21 days post-injection), T-HIF-1−/− mice show a significant increase in the percentage of CD4+ Foxp3+ cells.
“T-HIF-1−/− mice showed a significant increase in the percentage of CD4+ Foxp3+ cells during the recovery phase of disease (21 days post-injection), concomitant with a decrease in the proportion of IL-17+ CD4+ cells in T-HIF-1−/−animals (Figure 6D and 6E).”
Quote in the paperSubstantial claim - Findingown data
Absence of HIF-1 does not significantly affect IFN-γ or IL-4 production in T cells cultured under Th1 or Th2 conditions, respectively.
“We found that neither IFN-y nor IL-4 production was significantly affected by the absence of HIF-1 in T cells cultured under Th1 or Th2 conditions, Respectively.”
Quote in the paperSubstantial claim - Findingown data
Increasing amounts of Flag-tagged HIF-1α progressively decrease Foxp3 protein levels in co-transfected 293T cells.
“upon co-transfection of 293T cells with Foxp3 and increasing amounts of Flag-tagged HIF-1α, Foxp3 protein levels progressively decreased (Figure 5F).”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α might facilitate TH17 development through upregulation of RORγt.
“These results support the notion that HIF-1α might facilitate TH17 development through the upregulation of RORγt.”
Quote in the paperSubstantial claim - Interpretationown data
Hypoxia-induced enhancement of TH17 differentiation is HIF-1α-dependent.
“indicating that the hypoxia-induced enhancement of TH17 differentiation is HIF-1α-dependent.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α regulates multiple genes in the TH17 program.
“indicating that HIF-1α regulates multiple genes in the TH17 program (Figure 2B).”
- Also stated in: § Abstract · plain
“HIF-1α enhances TH17 development through direct transcriptional activation of RORvt, and via tertiary complex formation with RORvt and p300 recruitment to the IL17 promoter, thereby regulating TH17 signature genes.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Interpretationown data
HIF-1α expression is induced in T cells during TH17 differentiation in a Stat3-dependent manner.
“These findings confirm that HIF-1α expression is induced in T cells during TH17 differentiation in a Stat3-dependent manner.”
Quote in the paperSubstantial claim - Interpretationown data
DNA binding is dispensable for HIF-1α-mediated IL-17A expression.
“which implies that DNA binding is dispensable for HIF-1α-mediated IL-17A expression.”
Quote in the paperSubstantial claim - Interpretationreasoning
HIF-1α might be involved in Foxp3 protein modulation in addition to its role in transcriptional activation of the TH17 pathway.
“This implies that HIF-1α might be involved in Foxp3 protein modulation in addition to its role in the transcriptional activation of the TH17 pathway.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1 regulates the balance between Treg and TH17 differentiation.
“Here, we show that hypoxia-inducible factor 1 (HIF-1), a key metabolic sensor, regulates the balance between T regulatory (Treg) and TH17 differentiation.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α attenuates Treg development by binding Foxp3 and targeting it for proteasomal degradation.
“Concurrently, HIF-1α attenuates Treg development by binding Foxp3 and targeting it for proteasomal degradation.”
- Also stated in: § INTRODUCTION · plain
“In addition, HIF-1α inhibits Treg differentiation through an active process that targets Foxp3 protein for degradation.”
Quote in the paperSubstantial claim - Also stated in: § INTRODUCTION · plain
- Premisereasoning
Foxp3 can bind to the RORγt protein and antagonize its ability to bind DNA, pushing T cell differentiation away from TH17 and towards Treg.
“Foxp3 can in turn bind to the RORγt protein and antagonize its ability to bind DNA, thus pushing T cell differentiation away from the TH17 transcriptional program and towards the Treg lineage.”
Quote in the paperNot a substantial claim - Interpretationown data
HIF-1α's ability to promote IL-17A production is modulated by oxygen tension.
“These results suggest that, while active under normoxic conditions, HIF-1α’s ability to promote IL-17A production is indeed modulated by oxygen tension.”
Quote in the paperSubstantial claim - Interpretationown data
p300 is required for the full function of RORγt and HIF-1α in regulation of IL-17A gene expression.
“implying that p300 is required for the full function of RORγt and HIF-1α in the regulation of IL-17A gene expression (Figure S5E).”
Quote in the paperSubstantial claim - Premisecitation
p300 possesses histone acetyltransferase (HAT) activity.
“p300 possesses histone acetyltransferase (HAT) activity (Thompson et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Thompson et al., 2004 source
Not checked in the free run.
- Interpretationown data
HIF-1α directly transactivates RORγt gene expression.
“These results collectively indicate that HIF-1α directly transactivates RORγt gene expression.”
- Also stated in: § Abstract · plain
“HIF-1α enhances TH17 development through direct transcriptional activation of RORvt, and via tertiary complex formation with RORvt and p300 recruitment to the IL17 promoter, thereby regulating TH17 signature genes.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Interpretationown data
RORγt and HIF-1α, through recruitment of p300 to the IL-17A promoter, acetylate histones to open chromatin structure and facilitate gene expression.
“These findings indicate that RORγt and HIF-1α, through recruitment of p300 to the IL-17A promoter, acetylate histones to “open” the chromatin structure and facilitate gene expression.”
Quote in the paperSubstantial claim - Interpretationown data
There is a direct interaction between HIF-1α and RORγt in vitro.
“Taken together, these results suggested a direct interaction between the two proteins in vitro.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α has a potential role in promoting TH17 development in the context of microbial influences.
“indicating a potential role for HIF-1α in promoting TH17 development in the context of microbial influences.”
Quote in the paperSubstantial claim - Premisecitation
TH17 and Treg cells share a common requirement for TGF-β in their differentiation despite expressing distinct transcriptional regulators (RORγt vs. Foxp3) and demonstrating opposing functions.
“TH17 and Treg cells share a common requirement for TGF-p in their differentiation requirements despite expressing distinct transcriptional regulators (RORγt vs. Foxp3 respectively) and demonstrating opposing functions (inflammatory vs. anti-inflammatory)(Bettelli et al., 2006; Dong, 2008; Littman and Rudensky, 2010; Mangan et al., 2006; O'Quinn et al., 2008; Veldhoen et al., 2006).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
Hypoxic culture conditions have opposite effects on IL-17 and Foxp3 induction.
“Thus, hypoxi culture conditions have opposite effects on IL-17 and Foxp3 induction.”
Quote in the paperSubstantial claim - Premisecitation
The gut is relatively hypoxic under physiologic conditions.
“the gut, which is known to be relatively hypoxic under physiologic conditions (Koch, 2002)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Koch, 2002 source
Not checked in the free run.
- Interpretationown data
Under both Treg- and TH17-skewing conditions, HIF-1α down-regulates Foxp3 protein levels despite no effect on Foxp3 mRNA levels.
“These findings suggest that under both Treg- and TH17-skewing conditions, HIF-1α down-regulates Foxp3 protein levels despite demonstrating no effect on Foxp3 mRNA levels (Figure 5A).”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α can regulate RORγt gene expression.
“These results suggest that HIF-1α can regulate RORγt gene expression.”
Quote in the paperSubstantial claim - Premisecitation
In response to TGF-β in vitro as well as in vivo, many T cells co-express RORγt and Foxp3.
“In response to TGF-β in vitro as well as in vivo, many T cells co-express RORγt and Foxp3 (Veldhoen et al., 2006; Yang et al., 2008a).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Veldhoen et al., 2006 source
Not checked in the free run.
- cites Yang et al., 2008a
Not checked in the free run.
- Interpretationown data
HIF-1α is transcriptionally activated via Stat3 signaling in differentiating T cells.
“Collectively, these in vitro differentiation studies, alongside our transcriptional and biochemical analyses, suggest a model in which HIF-1α is transcriptionally activated via Stat3 signaling in differentiating T cells, resulting in the enhancement of the TH17 genetic program via a RORγt/p300-dependent mechanism and repression of the Treg transcriptional program through induced degradation of Fox”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α mediates Foxp3 degradation via PHD-VHL-ubiquitin-mediated proteasomal degradation.
“Collectively, these results are compatible with a scenario in which HIF-1α mediates Foxp3 degradation via PHD-VHL-Ubiquitin-mediated proteasomal degradation, although future studies are needed to delineate precisely how HIF-1α protein turnover dynamics in T cells modulate Foxp3 levels.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α represses the Treg transcriptional program through induced degradation of Foxp3.
“Collectively, these in vitro differentiation studies, alongside our transcriptional and biochemical analyses, suggest a model in which HIF-1α is transcriptionally activated via Stat3 signaling in differentiating T cells, resulting in the enhancement of the TH17 genetic program via a RORγt/p300-dependent mechanism and repression of the Treg transcriptional program through induced degradation of Fox”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α enhances the TH17 genetic program via a RORγt/p300-dependent mechanism.
“Collectively, these in vitro differentiation studies, alongside our transcriptional and biochemical analyses, suggest a model in which HIF-1α is transcriptionally activated via Stat3 signaling in differentiating T cells, resulting in the enhancement of the TH17 genetic program via a RORγt/p300-dependent mechanism and repression of the Treg transcriptional program through induced degradation of Fox”
Quote in the paperSubstantial claim - Interpretationown data
In vivo experiments validate the role of HIF-1α identified by in vitro studies.
“These experiments validate the role of HIF-1α identified by our in vitro studies and further suggest the possibility for metabolic modulation of autoimmune diseases.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α promotes TH17 development through direct transcriptional activation of RORγt.
“Specifically, HIF-1α promotes TH17 development through: a) direct transcriptional activation of RORγt, the major TH17 transcription factor, and b) direct collaboration with RORγt to activate TH17 signature genes, such as IL-17A, through mechanisms involving p300 recruitment and histone acetylation.”
Quote in the paperSubstantial claim - Premisecitation
The lamina propria of the gut is relatively hypoxic.
“the lamina propria of the gut, which, as indicated above (Koch, 2002), is relatively hypoxic”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Koch, 2002 source
Not checked in the free run.
- Interpretationown data
HIF-1α plays a role in modulating the TH17/Treg balance.
“This altered balance between Treg cells and TH17 cells exactly parallels our in vitro culture studies and suggests that HIF-1α indeed plays a role in modulating the TH17/Treg balance.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α directly collaborates with RORγt to activate TH17 signature genes such as IL-17A through mechanisms involving p300 recruitment and histone acetylation.
“Specifically, HIF-1α promotes TH17 development through: a) direct transcriptional activation of RORγt, the major TH17 transcription factor, and b) direct collaboration with RORγt to activate TH17 signature genes, such as IL-17A, through mechanisms involving p300 recruitment and histone acetylation.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1α inhibits differentiation toward the Treg lineage through a distinct, non-transcriptional mechanism.
“HIF-1α inhibits differentiation toward the Treg lineage through a distinct, non-transcriptional mechanism.”
Quote in the paperSubstantial claim - Interpretationown data
HIF-1 targets Foxp3 for ubiquitination and proteasomal degradation using the same ubiquitin ligase system responsible for degradation of HIF-1α itself.
“We show that HIF-1 targets Foxp3 for ubiquitination and proteasomal degradation, using the same ubiquitin ligase system that is responsible for degradation of HIF-1α itself (Figure 7).”
Quote in the paperSubstantial claim
- May combine two claims. 18
- Classified as probably not a substantial claim. 15
May combine two claims.
Findingown dataIn naïve T cells activated under TH17 skewing conditions (TGF-β + IL-6), HIF-1α mRNA increases, peaks after 48 hours, then declines.
“When naïve T cells were activated in the presence of TGF-β + IL-6 (TH17 skewing conditions), HIF-1α mRNA increased, peaked after 48 hours of culture and then began to decline (Figure 1B)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHIF-1β expression is constitutive under all treatments, while TGF-β and IL-6 alone induce HIF-1α and their combination generates significantly higher HIF-1α protein under normoxic conditions.
“While HIF-1β expression was constitutive as expected under all treatments, both TGF-β and IL-6 alone induced HIF-1α and the combination of the two generated significantly higher levels of HIF-1α protei ven under normoxic conditions (Figure 1E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataStat3 is directly associated with the promoter region of HIF-1α in WT TH17-skewed T cells, but not at the GAPDH promoter.
“Stat3 was directly associated with the promoter region of HIF-1α in the WT TH17-skewed T cells, but not at the promoter region of GAPDH (Figure 1F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHuman and mouse RORγt promoter sequences share a high degree of identity as well as a conserved HRE.
“Since the human and mouse RORγt promoter sequences share a high degree of identity as well as a conserved HRE (Figure S3A)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHIF-1α binds to several HREs located at the RORγt promoter, but not the promoter of the non-HIF-1α-regulated Gmpr gene.
“HIF-1α was found bind to several HREs located at the RORγt promoter, but not the promoter of the non-HIF-1α-regulated Gmpr gene (Figure 3C and Figure S4A–D).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMetabolic cues modulate T cell differentiation and HIF-1α is an important mediator of this effect.
“These findings support the idea that metabolic cues modulate T cell differentiation and that HIF-1α is an important mediator of this effect.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataHIF-1α deficiency specifically affects the TH17 pathway, as opposed to creating a global defect in T cell proliferation or differentiation capacity.
“These results suggest that HIF-1α deficiency specifically affects the TH17 pathway, as opposed to creating a global defect in T cell proliferation or differentiation capacity.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPro-inflammatory cytokines such as IL-6 or IL-21 in the presence of low TGF-β activate Stat3, which overcomes Foxp3 inhibition of RORγt transcriptional activity, leading to up-regulation of IL-23R and pushing T cell differentiation toward TH17.
“On the other hand, pro-inflammatory cytokines such as IL-6 or IL-21 in the presence of low TGF-β activate Stat3, which overcomes Foxp3 inhibition of RORγt transcriptional activity. This leads to the up-regulation of the IL-23R, thus pushing T cell differentiation toward a TH17 fate (Zhou et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhou et al., 2008
Not checked in the free run.
May combine two claims.
Interpretationown dataHIF-1α plays a dual role in regulating IL-17A transcriptional activity by directly activating RORγt transcription and then associating with RORγt at the IL-17A promoter to recruit p300, thus generating a permissive chromatin structure.
“Taken together, these results demonstrate that HIF-1α plays a dual role in regulating IL-17A transcriptional activity by directly activating RORγt transcription and then associating with RORγt at the IL-17A promoter to recruit p300, thus generating a permissive chromatin structure.”
- Also stated in: § INTRODUCTION · boosted
“Specifically, we have discovered that HIF-1α promotes TH17 differentiation by directly inducing RORγt transcription and subsequently collaborates with RORγt to regulate downstream TH17 genes.”
Quote in the paperSubstantial claim- Also stated in: § INTRODUCTION · boosted
Classified as probably not a substantial claim.
PremisecitationThe defect in TH17 differentiation seen in the absence of Stat3 can be only partially rescued by RORγt overexpression.
“Interestingly, the defect in TH17 differentiation seen in the absence of Stat3 can be only partially rescued by RORγt overexpression (Yang et al., 2008b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Yang et al., 2008b
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIL-6, IL-21 and IL-23 all activate Stat3, which is critical for the effects of these cytokines on TH17 cell differentiation.
“Interestingly, IL-6, IL-21 and IL-23 all activate Stat3, which is critical for the effects of these cytokines on TH17 cell differentiation (Zhou et al., 2007; (Harris et al., 2007).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Zhou et al., 2007
Not checked in the free run.
- cites Harris et al., 2007
Not checked in the free run.
May combine two claims.
Premisenone givenHigh TGF-β levels in the absence of IL-6 induce Foxp3 and repress IL-23R transcription.
“High TGF-β levels in the absence of IL-6 induce Foxp3 and repress IL-23R transcription.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAccumulating evidence suggests that TH17 and iTreg arise from a common precursor.
“Interestingly, accumulating evidence suggests that TH17 and iTreg arise from a common precursor.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHIF-1α mediates the metabolic switch from oxidative phosphorylation to aerobic glycolysis in response to hypoxia.
“hypoxia-inducible factor 1α (HIF-1α), the transcription factor that mediates the metabolic switch from oxidative phosphorylation to aerobic glycolysis in response to hypoxia (Semenza, 2007)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Semenza, 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBoth iTreg and nTreg express Foxp3 as a core subset-specific transcription factor.
“Both iTreg and nTreg express Foxp3 as a core subset-specific transcription factor, which activates a large bank of genes that mediate the suppressive phenotype of Treg and also silences many effector T cell genes (Getnet et al., 2010; Pan et al., 2009; Sakaguchi et al., 2008).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Getnet et al., 2010
Not checked in the free run.
- cites Pan et al., 2009
Not checked in the free run.
- cites Sakaguchi et al., 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenTH17 cells are induced by IL-6 and TGF-β and propagated by IL-23 and IL-21.
“TH17 cells are induced by IL-6 and TGF-p and propagated by IL-23 and IL-21.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHIF-1α expression in T cells can be induced by hypoxic and non-hypoxic stimuli, including TCR-triggered and PI3K-mediated pathways, resulting in mRNA up-regulation and protein stabilization.
“HIF-1α expression in T cells can be induced both by hypoxic and non-hypoxic stimuli, including TCR-triggered and PI3K–mediated pathways, that result in mRNA up-regulation and protein stabilization (Lukashev et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lukashev et al., 2006 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTGF-β induces Foxp3 expression in peripheral naïve T cells leading to differentiation of iTregs.
“TGF-β induces Foxp3 expression in peripheral naïve T cells leading to the differentiation of iTregs, which exhibit a suppressive phenotype similar to that seen in nTreg cells (Sakaguchi et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sakaguchi et al., 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTregs can be induced from naïve T cells upon exposure to TGF-β and are propagated by IL-2.
“Tregs can be induced from naïve T cells upon exposure to TGF-β and are propagated by IL-2 (Chen et al., 2003; Davidson et al., 2007; Rajewsky and von Boehmer, 2008).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Chen et al., 2003
Not checked in the free run.
- cites Davidson et al., 2007
Not checked in the free run.
- cites Rajewsky and von Boehmer, 2008
Not checked in the free run.
May combine two claims.
Interpretationown dataHIF-1α not only directly mediates RORγt gene expression, but also is required for the full function of RORγt in IL-17A gene transcription.
“These results suggest that HIF-1α not only directly mediates RORγt gene expression, but also is required for the full function of RORγt in IL-17A gene transcription.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationHIF-1α is a target gene for activated Stat3 in tumor cells.
“our previous observation that HIF-1α is a target gene for activated Stat3 in tumor cells (Harris et al., 2007; Xu et al., 2005)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Harris et al., 2007
Not checked in the free run.
- cites Xu et al., 2005
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStat3 induces RORγt gene expression.
“While it is now known that Stat3 induces RORyt gene expression (Harris et al., 2007; Yang et al., 2007) - the key transcription factor required for TH17 development (Ivanov et al., 2006)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Harris et al., 2007
Not checked in the free run.
- cites Yang et al., 2007
Not checked in the free run.
- cites Ivanov et al., 2006 source
Not checked in the free run.
May combine two claims.
Interpretationown dataHIF-1α plays a role in setting the TH17/Treg balance in a TH17-dependent disease model, and the mechanisms defined in the in vitro differentiation assays are operative in vivo.
“Taken together, these results support the notion that HIF-1α plays a role in setting the TH17/Treg balance in a TH17-dependent disease model and that the mechanisms defined in the in vitro differentiation assays are also operative in vivo (Figure 7).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningHIF-1α-mediated Foxp3 degradation would be expected to diminish Foxp3 gene transcriptional activity, antagonizing stable Foxp3 autoregulation and Treg lineage commitment.
“Thus, degradation of Foxp3 in TH17/Treg progenitors mediated by HIF-1α would be expected to eventually diminish Foxp3 gene transcriptional activity thereby antagonizing stable Foxp3 autoregulation and consequent Treg lineage commitment.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
PremisecitationHIF-1α activity in T cells is a general negative regulator of T cell activation.
“Sitkovsky and colleagues have suggested that HIF-1α activity in T cells is a general negative regulator of T cell activation (Lukashev et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lukashev et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationEAE is a TH17-dependent disease whose remission is dependent upon Treg cells.
“a TH17-dependent disease whose remission is dependent upon Treg cells (Schraml et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schraml et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAnimal protocols were approved by the Johns Hopkins Animal Care and Use Committee.
“Animal protocols were approved by the Johns Hopkins Animal Care and Use Committee.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted).
PremisecitationConserved noncoding sequence 2 (CNS2) in the Foxp3 gene represents a site for positive transcriptional autoregulation of Foxp3, providing a mechanism for the protein to maintain its own expression levels.
“Rudensky and colleagues have recently proposed that conserved noncoding sequence 2 (CNS2) in the Foxp3 gene represents a site for positive transcriptional autoregulation of Foxp3, providing a mechanism for the protein to maintain its own expression levels (Zheng et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zheng et al., 2010
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationTH17 cytokines can inhibit Th1/IFN-γ development in some circumstances.
“Because TH17 cytokines can inhibit Th1/IFN-γ development in some circumstances (Luger et al., 2008)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Luger et al., 2008
Not checked in the free run.
The paper relies on this without support.
p300 is critical for HIF-1α-mediated gene activation under hypoxic conditions.
“Because it has been shown that the transcription factor p300 is critical for HIF-1α-mediated gene activation under hypoxic conditions, we hypothesized that HIF-1α might function in a complex with RORγt by recruiting p300 to activate target genes such as IL-17A.”
The paper relies on this without support.
Inflammatory environments are relatively hypoxic.
“a number of studies have demonstrated that inflammatory environments are, relatively hypoxic.”
The paper relies on this without support.
TH17 cells are the major pathogenic population in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis.
“TH17 cells are the major pathogenic population in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis, although factors besides IL-17A and IL-17F can contribute to the disease.”
The paper relies on this without support.
Immunization of B6 mice with MOG35–55 in complete Freund’s adjuvant (CFA) induces a TH17-dependent response that induces encephalitis.
“Immunization of B6 mice with myelin oligodendrocyte glycoprotein peptide (MOG35–55) in complete Freund’s adjuvant (CFA) induces a TH17-dependent response that induces encephalitis.”
The paper relies on this without support.
After a peak of encephalitis, the disease remits, concomitant with expansion of Tregs that can silence the TH17 encephalitic process.
“After a peak of encephalitis, clinically discernible by various gradable neurologic signs (including tail paralysis, progressing to hind and front limb paralysis) the disease remits, concomitant with expansion of Tregs that can silence the TH17 encephalitic process.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Genetic defects in the human IL-17/IL-17-receptor axis, STAT3, or RORγt that cause dysfunctional Th17 cells are associated with chronic mucocutaneous candidiasis and severe disease after BCG immunization.
“genetic defects in humans in the IL-17/IL-17-receptor axis, STAT3, and RORγt, resulting in dysfunctional Th17 cells, are associated with chronic mucocutaneous candidiasis and severe disease following BCG immunization”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [68]
TH17 cell development is promoted by HIF-1α, which regulates glycolytic gene expression in TH17 cells.
“TH17 cell development is promoted by hypoxia inducible factor–1α (HIF-1α) (35, 36), an oxygen-sensitive transcription factor that regulates glycolytic gene expression in TH17 cells.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [36]
HIF-1α has been shown to be involved in degradation of Foxp3 and induce the Th17 phenotype.
“While HIF-1α has been shown to be involved in degradation of Foxp3 and induce the Th17 phenotype (26)”
From Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues (2022) · cites this paper as [26]
Culture with IL-6 activates STAT3 and induces Hif-1α in T cells.
“A second mechanism of Hif-1α induction in T cells is mediated by culture with the pro-inflammatory cytokine IL-6, which activates the STAT3 transcription factor [71].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [71]
In T cells, HIF-1α is transiently stabilized following TCR activation and plays an important role in regulating Treg and Th17 balance.
“In T cells, HIF-1α is transiently stabilized in T cells following TCR activation (41), and plays an important role in regulating Treg and Th17 balance (26).”
From Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues (2022) · cites this paper as [26]
T cells lacking Hif-1α have impaired Th17 differentiation and increased production of Tregs.
“T cells lacking Hif-1α had impaired Th17 differentiation and increased production of Tregs.”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [71]
Hif-1α is required for the induction of experimental autoimmune encephalitis, a Th17-driven murine model of autoimmunity.
“both groups showed that Hif-1α was required for the induction of experimental autoimmune encephalitis, a Th17-driven murine model of autoimmunity.”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [71]
Hif-1α promotes production of pro-inflammatory Th17 cells while simultaneously limiting generation of Tregs.
“two recent reports identified an alternative role for Hif-1α in T cell differentiation in promoting the production of pro-inflammatory Th17 cells while simultaneously limiting the generation of Tregs [71, 97].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [71]
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · see citing works
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,357 · see citing works
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145 · see citing works
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · see citing works
Chen, W., Jin, W., Hardegen, N. J., Lei, K.-J., Li, L., Marinos, N. J., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,678 · see citing works
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 2× · see citing works
“In response toTGF-b in vitro as well as in vivo, many T cells coexpress RORgt and Foxp3 (Veldhoen et al., 2006; Yang et al., 2008a).”
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · see citing works
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · see citing works
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,255 · see citing works
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., et al. (2008) · Nature · doi:10.1038/nature06878 · Cited by 1,866 · see citing works
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · see citing works
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812 · see citing works
Self-citationShi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803 · see citing works
The lineage decisions of helper T cells
MURPHY, K. M. M., & Reiner, S. L. (2002) · Nature reviews. Immunology · doi:10.1038/nri954 · Cited by 1,675 · see citing works
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634 · see citing works
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605 · see citing works
STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells
Yang, X. O., Panopoulos, A. D., Nurieva, R., Chang, S. H., Wang, D., Watowich, S. S., & Dong, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600321200 · Cited by 1,494 · see citing works
mTOR differentially regulates effector and regulatory T cell lineage commitment
Delgoffe, G. M., Kole, T., Zheng, Y., Zarek, P. E., Matthews, K., Xiao, B., Worley, P., Kozma, S., & Powell, J. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,293 · see citing works
Self-citationRole of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate
Zheng, Y., Josefowicz, S. Z., Chaudhry, A., Peng, X. P., Forbush, K. A., & Rudensky, A. Y. (2010) · Nature · doi:10.1038/nature08750 · Cited by 1,170 · see citing works
Self-citationMolecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs
Yang, X. O., Nurieva, R., Martínez, G., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B., Chang, S. H., Schluns, K. S., Watowich, S. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.007 · Cited by 1,129 · see citing works
Delgoffe, G. M., Pollizzi, K. N., Waickman, A. T., Heikamp, E., Meyers, D. J., Horton, M. R., Xiao, B., Worley, P. F., & Powell, J. D. (2011) · Nature Immunology · doi:10.1038/ni.2005 · Cited by 1,111 · see citing works
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064 · see citing works
Th17 and regulatory T cells in mediating and restraining inflammation
Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039 · see citing works
Hypoxia-Inducible Factor 1 (HIF-1) Pathway
Semenza, G. L. (2007) · Science s STKE · doi:10.1126/stke.4072007cm8 · Cited by 942 · see citing works
Self-citationAn essential role for p300/CBP in the cellular response to hypoxia
Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12969 · Cited by 790 · see citing works
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Kangas, T. O., Wu, J. Q., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759 · see citing works
Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
Durant, L. R., Watford, W. T., Ramos, H. L., Laurence, A. D. J., Vahedi, G., Wei, L., Takahashi, H., Sun, H., Kanno, Y., Powrie, F. M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.003 · Cited by 731 · see citing works
Luger, D., Silver, P. B., Tang, J., Cua, D., Chen, Z., Iwakura, Y., Bowman, E. P., Sgambellone, N. M., Chan, C., & Caspi, R. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071258 · Cited by 721 · see citing works
Bauquet, A. T., Jin, H., Paterson, A. M., Mitsdoerffer, M., Ho, I.-C., Sharpe, A. H., & Kuchroo, V. K. (2009) · Nature Immunology · doi:10.1038/ni.1690 · Cited by 713 · see citing works
The AP-1 transcription factor Batf controls TH17 differentiation
Schraml, B. U., Hildner, K. M., Ise, W., Lee, W.-L., Smith, W. A.-E., Solomon, B. D., Sahota, G., Sim, J. E., Mukasa, R., Čemerski, S., et al. (2009) · Nature · doi:10.1038/nature08114 · Cited by 632 · see citing works
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624 · cited 1× · see citing works
“Other transcription factors have been identified to contribute to the induction of IL-17A in TH17- polarized cells: Runx1 (Zhang et al., 2008), BATF (Schraml et al.”
Self-citationHarris, T. J., Grosso, J. F., Yen, H., Xin, H., Kortylewski, M., Albesiano, E., Hipkiss, E. L., Getnet, D., Goldberg, M. V., Maris, C. H., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4313 · Cited by 585 · see citing works
Self-citationXu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H. D., Semenza, G. L., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208719 · Cited by 576 · see citing works
Self-citationInterleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
Ahern, P. P., Schiering, C., Buonocore, S., McGeachy, M. J., Cua, D. J., Maloy, K. J., & Powrie, F. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.010 · Cited by 528 · see citing works
Cutting Edge: IL-2 Is Essential for TGF-β-Mediated Induction of Foxp3+ T Regulatory Cells
Davidson, T. S., DiPaolo, R. J., Andersson, J., & Shevach, E. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4022 · Cited by 520 · see citing works
Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V., Galileos, G., Vollmar, P., Stritesky, G. L., Kaplan, M. H., Waisman, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809850105 · Cited by 510 · see citing works
Regulation of the p300 HAT domain via a novel activation loop
Thompson, P. R., Wang, D., Wang, L., Fulco, M., Pediconi, N., Zhang, D., An, W., Ge, Q., Roeder, R. G., Wong, J., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb740 · Cited by 423 · see citing works
Regulatory T Cells Reinforce Intestinal Homeostasis
Barnes, M. J., & Powrie, F. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.011 · Cited by 377 · see citing works
Eos Mediates Foxp3-Dependent Gene Silencing in CD4 + Regulatory T Cells
Pan, F., Yu, H., Dang, E. V., Barbi, J. J., Pan, X., Grosso, J. F., Jinasena, D., Sharma, S. M., McCadden, E., Getnet, D., et al. (2009) · Science · doi:10.1126/science.1176077 · Cited by 335 · see citing works
Self-citationA role for the transcription factor Helios in human CD4+CD25+ regulatory T cells
Getnet, D., Grosso, J. F., Goldberg, M. V., Harris, T., Yen, H., Bruno, T. C., Durham, N. M., Hipkiss, E. L., Pyle, K. J., & Wada, S. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.001 · Cited by 248 · see citing works
Self-citationIntegration of calcineurin and MEF2 signals by the coactivator p300 during T‐cell apoptosis
Youn, H., Chatila, T. A., & Liu, J. O. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4323 · Cited by 223 · see citing works
Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., Berenfeld, L., Wenger, R. H., Ohta, A., & Sitkovsky, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.4962 · Cited by 208 · see citing works
Koch, C. J. (2002) · Methods in Enzymology · doi:10.1016/s0076-6879(02)52003-6 · Cited by 207 · see citing works
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
Hot, A., & Miossec, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143768 · Cited by 199 · see citing works
Redox regulation of the hypoxia-inducible factor
Pouysségur, J., & Mechta-Grigoriou, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.167 · Cited by 186 · see citing works
Chapter 5 Emergence of the Th17 Pathway and Its Role in Host Defense
O’Quinn, D. B., Palmer, M. T., Lee, Y. K., & Weaver, C. T. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00605-6 · Cited by 126 · see citing works
mTOR: taking cues from the immune microenvironment
Delgoffe, G. M., & Powell, J. D. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03125.x · Cited by 110 · see citing works
Calmodulin‐dependent protein kinase IV regulates nuclear export of Cabin1 during T‐cell activation
Pan, F., Means, A. R., & Liu, J. O. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600685 · Cited by 40 · see citing works
Self-citationLymphocyte development: overview
Rajewsky, K., & von Boehmer, H. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.005 · Cited by 11 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Harris, T.J., Grosso, J.F., Yen, H.R., Xin, H., Kortylewski, M., Albesiano, E., Hipkiss, E.L., Getnet, D., Goldberg, M.V., Maris, C.H., et al. (2007). Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 179, 4313–4317. · DOI
- Pan, F., Means, A.R., and Liu, J.O. (2005). Calmodulin-dependent protein kinase IV regulates nuclear export of Cabin1 during T-cell activation. EMBO J. 24, 2104–2113. · DOI
- Schraml, B.U., Hildner, K., Ise, W., Lee, W.L., Smith, W.A., Solomon, B., Sahota, G., Sim, J., Mukasa, R., Cemerski, S., et al. (2009). The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 460, 405–409. · DOI
- Wu, S., Rhee, K.J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.R., Huso, D.L., Brancati, F.L., Wick, E., McAllister, F., et al. (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016–1022. · DOI · Paper page
Cited by
Sorted by citations
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · see citing works
Self-citationDang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390 · see citing works
Self-citationThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · see citing works
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612 · see citing works
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
Togashi, Y., Shitara, K., & Nishikawa, H. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0175-7 · Cited by 1,553 · see citing works
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363 · see citing works
Metabolic Regulation of T Lymphocytes
MacIver, N. J., Michalek, R. D., & Rathmell, J. C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095956 · Cited by 1,244 · see citing works
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267 · see citing works
Kawalekar, O. U., O’Connor, R. S., Fraietta, J. A., Guo, L., McGettigan, S. E., Posey, A. D., Patel, P. R., Guedan, S., Scholler, J., Keith, B., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.021 · Cited by 1,234 · see citing works
Metabolic Instruction of Immunity
Buck, M. D., Sowell, R., Kaech, S. M., & Pearce, E. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.004 · Cited by 1,232 · see citing works
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195 · see citing works
T cell metabolism drives immunity
Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,190 · see citing works
A Validated Regulatory Network for Th17 Cell Specification
Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A., Huang, W., Parkurst, C. N., Muratet, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.016 · Cited by 1,160 · see citing works
Metabolism of Inflammation Limited by AMPK and Pseudo-Starvation
O'Neill, L. A. J., & Hardie, D. G. (2013) · Nature · doi:10.1038/nature11862 · Cited by 1,133 · see citing works
Yang, W., Yu, T., Huang, X., Bilotta, A. J., Xu, L., Lu, Y., Sun, J., Pan, F., Zhou, J., Zhang, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18262-6 · Cited by 1,060 · see citing works
Self-citationRegulation and function of mTOR signalling in T cell fate decisions
Chi, H. (2012) · Nature Reviews Immunology · doi:10.1038/nri3198 · Cited by 1,035 · see citing works
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,060 · see citing works
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico‐Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,035 · see citing works
Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions
Palmer, C. S., Ostrowski, M., Balderson, B., Christian, N., & Crowe, S. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00001 · Cited by 992 · see citing works
Regulation of the immune response by the aryl hydrocarbon receptor
Gutiérrez-Vázquez, C., & Quintana, F. J. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.012 · Cited by 985 · see citing works
Mitochondria in the Regulation of Innate and Adaptive Immunity
Weinberg, S. E., Sena, L. A., & Chandel, N. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.002 · Cited by 960 · see citing works
CD69: from activation marker to metabolic gatekeeper
Cibrián, D., & Sánchez‐Madrid, F. (2017) · European Journal of Immunology · doi:10.1002/eji.201646837 · Cited by 948 · see citing works
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3704 · Cited by 927 · see citing works
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877 · see citing works
The Balance of Th17 versus Treg Cells in Autoimmunity
Lee, G. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030730 · Cited by 868 · see citing works
The role of HIF in immunity and inflammation
McGettrick, A. F., & O’Neill, L. A. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.002 · Cited by 768 · see citing works
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 774 · see citing works
HIF1α and metabolic reprogramming in inflammation
Corcoran, S. E., & O'Neill, L. A. J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84431 · Cited by 789 · see citing works
Maj, T., Wang, W., Crespo, J., Zhang, H., Wang, W., Wei, S., Zhao, L., Vatan, L., Shao, I., Szeliga, W., et al. (2017) · Nature Immunology · doi:10.1038/ni.3868 · Cited by 733 · see citing works
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Gerriets, V. A., Kishton, R. J., Nichols, A., Macintyre, A. N., Inoue, M., Ilkayeva, O., Winter, P. S., Liu, X., Priyadharshini, B., Slawinska, M. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76012 · Cited by 729 · see citing works
Succinate: a metabolic signal in inflammation
Mills, E., & O’Neill, L. A. J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.008 · Cited by 741 · see citing works
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Virgilio, F. D., Sarti, A. C., Falzoni, S., Marchi, E. D., & Adinolfi, E. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0037-0 · Cited by 730 · see citing works
Development and Maintenance of Regulatory T cells
Ohkura, N., Kitagawa, Y., & Sakaguchi, S. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.002 · Cited by 728 · see citing works
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 713 · see citing works
Regulation of Immunity and Inflammation by Hypoxia in Immunological Niches
Taylor, C. T., & Colgan, S. P. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.103 · Cited by 713 · see citing works
Regulatory T cells in autoimmune disease
Dominguez-Villar, M., & Hafler, D. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0120-4 · Cited by 713 · see citing works
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen
Doedens, A. L., Phan, A. T., Stradner, M. H., Fujimoto, J. K., Nguyen, J. V., Yang, E., Johnson, R. S., & Goldrath, A. W. (2013) · Nature Immunology · doi:10.1038/ni.2714 · Cited by 660 · see citing works
Glycolysis – a key player in the inflammatory response
Soto‐Heredero, G., Heras, M. M. G. D. L., Gabandé‐Rodríguez, E., Oller, J., & Mittelbrunn, M. (2020) · FEBS Journal · doi:10.1111/febs.15327 · Cited by 645 · see citing works
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Overacre-Delgoffe, A. E., Chikina, M., Dadey, R. E., Yano, H., Brunazzi, E. A., Shayan, G., Horne, W., Moskovitz, J. M., Kolls, J. K., Sander, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.005 · Cited by 627 · see citing works
Normalization of CD4 + T cell metabolism reverses lupus
Yin, Y., Choi, S., Xu, Z., Perry, D. J., Seay, H. R., Croker, B. P., Sobel, E. S., Brusko, T. M., & Morel, L. M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0835 · Cited by 611 · see citing works
The regulation of immune tolerance by FOXP3
Lu, L., Barbi, J., & Pan, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.75 · Cited by 580 · see citing works
Self-citationMicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells
Okoye, I., Coomes, S. M., Pelly, V. S., Czieso, S., Papayannopoulos, V., Tolmachova, T., Seabra, M. C., & Wilson, M. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.019 · Cited by 604 · see citing works
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., Tuccitto, A., Tagliabue, E., Castelli, C., & Rivoltini, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.001 · Cited by 595 · see citing works
Cytokine Regulation and Function in T Cells
Dong, C. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-061020-053702 · Cited by 594 · see citing works
Molecular regulation of effector and memory T cell differentiation
Chang, J. T., Wherry, E. J., & Goldrath, A. W. (2014) · Nature Immunology · doi:10.1038/ni.3031 · Cited by 578 · see citing works
HIF ‐1 at the crossroads of hypoxia, inflammation, and cancer
Balamurugan, K. (2015) · International Journal of Cancer · doi:10.1002/ijc.29519 · Cited by 572 · see citing works
PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
Xie, M., Yu, Y., Kang, R., Zhu, S., Yang, L., Zeng, L., Sun, X., Yang, M., Billiar, T. R., Wang, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13280 · Cited by 567 · see citing works
Induced CD4<sup>+</sup>Foxp3<sup>+</sup>Regulatory T Cells in Immune Tolerance
Bilate, A. M., & Lafaille, J. J. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075043 · Cited by 569 · see citing works
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560 · see citing works
The pathogenicity of Th17 cells in autoimmune diseases
Yasuda, K., Takeuchi, Y., & Hirota, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00733-8 · Cited by 559 · see citing works
Caro‐Maldonado, A., Wang, R., Nichols, A., Kuraoka, M., Milasta, S., Sun, L., Gavin, A. L., Abel, E. D., Kelsoe, G. H., Green, D. R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302062 · Cited by 553 · see citing works
The updated biology of hypoxia-inducible factor
Greer, S. N., Metcalf, J. L., Wang, Y., & Ohh, M. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.125 · Cited by 545 · see citing works
Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.
Tretter, L., Patócs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta · doi:10.1016/j.bbabio.2016.03.012 · Cited by 502 · see citing works
Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression
Gerriets, V. A., Kishton, R. J., Johnson, M. O., Cohen, S., Siska, P. J., Nichols, A., Warmoes, M. O., de Cubas, A. A., MacIver, N. J., Locasale, J. W., et al. (2016) · Nature Immunology · doi:10.1038/ni.3577 · Cited by 542 · see citing works
Dendritic cell migration in inflammation and immunity
Liu, J., Zhang, X., Cheng, Y., & Cao, X. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00726-4 · Cited by 543 · see citing works
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Palazon, A., Tyrakis, P. A., Macias, D., Veliça, P., Rundqvist, H., Fitzpatrick, S., Vojnovic, N., Phan, A. T., Loman, N., Hedenfalk, I., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.003 · Cited by 521 · see citing works
“The VHL-HIF axis is essential for Treg function, as HIF-1a promotes FOXP3 proteasomal degradation (Dang et al., 2011; Shi et al., 2011) and binds to the IFNg promoter to drive T helper 1 responses (Lee et al.”
InfluentialThe Warburg effect then and now: From cancer to inflammatory diseases
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2013) · BioEssays · doi:10.1002/bies.201300084 · Cited by 538 · see citing works
The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome
Omenetti, S., & Pizarro, T. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00639 · Cited by 528 · see citing works
Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease
DuPage, M. J. P., & Bluestone, J. A. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2015.18 · Cited by 507 · see citing works
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
Weinberg, F., Ramnath, N., & Nagrath, D. (2019) · Cancers · doi:10.3390/cancers11081191 · Cited by 502 · see citing works
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
Vasquez-Dunddel, D., Pan, F., Zeng, Q., Gorbounov, M., Albesiano, E., Fu, J. L., Blosser, R. L., Tam, A. J., Bruno, T. C., Zhang, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60083 · Cited by 508 · see citing works
Self-citationHypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499 · see citing works
PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis
Yang, L., Xie, M., Yang, M., Yu, Y., Zhu, S., Hou, W., Kang, R., Lotze, M. T., Billiar, T. R., Wang, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms5436 · Cited by 503 · see citing works
Saravia, J., Chapman, N. M., & Chi, H. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0220-6 · Cited by 489 · see citing works
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 477 · see citing works
Basic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 477 · see citing works
Obesity, Inflammation, and Immune System in Osteoarthritis
Nedunchezhiyan, U., Varughese, I., Sun, A. R., Wu, X., Crawford, R., & Prasadam, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907750 · Cited by 487 · see citing works
Metabolic checkpoints in activated T cells
Wang, R., & Green, D. R. (2012) · Nature Immunology · doi:10.1038/ni.2386 · Cited by 457 · see citing works
A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?
Wen, H., Ting, J. P. ‐., & O'Neill, L. A. J. (2012) · Nature Immunology · doi:10.1038/ni.2228 · Cited by 455 · see citing works
Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis
Fearon, U., Canavan, M., Biniecka, M., & Veale, D. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.69 · Cited by 445 · see citing works
Th17 cells are long lived and retain a stem cell-like molecular signature
Muranski, P., Borman, Z. A., Kerkar, S. P., Klebanoff, C. A., Ji, Y., Sanchez-Perez, L., Sukumar, M., Reger, R. N., Yu, Z., Kern, S. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.019 · Cited by 443 · see citing works
Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α
Mascanfroni, I. D., Takenaka, M. C., Yeste, A., Patel, B., Wu, Y., Kenison, J. E., Siddiqui, S., Basso, A. S., Otterbein, L. E., Pardoll, D. M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3868 · Cited by 441 · see citing works
Self-citationMetabolic pathways in T cell fate and function
Gerriets, V. A., & Rathmell, J. C. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.01.010 · Cited by 425 · see citing works
Transcription factor Foxp3 and its protein partners form a complex regulatory network
Rudra, D., DeRoos, P. C., Chaudhry, A., Niec, R. E., Arvey, A. J., Samstein, R. M., Leslie, C. S., Shaffer, S. A., Goodlett, D. R., & Rudensky, A. Y. (2012) · Nature Immunology · doi:10.1038/ni.2402 · Cited by 431 · see citing works
The ever-expanding role of HIF in tumour and stromal biology
LaGory, E. L., & Giaccia, A. J. (2016) · Nature Cell Biology · doi:10.1038/ncb3330 · Cited by 432 · see citing works
Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells
Okkenhaug, K. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095946 · Cited by 446 · see citing works
<scp>mTOR</scp> , metabolism, and the regulation of T‐cell differentiation and function
Waickman, A. T., & Powell, J. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01152.x · Cited by 420 · see citing works
The spectrum of T cell metabolism in health and disease
Bantug, G. R., Galluzzi, L., Kroemer, G., & Hess, C. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.99 · Cited by 421 · see citing works
Treg and CTLA-4: Two intertwining pathways to immune tolerance
Walker, L. S. K. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.006 · Cited by 411 · see citing works
Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability
Huynh, A., DuPage, M. J. P., Priyadharshini, B., Sage, P. T., Quiros, J., Borges, C. M., Townamchai, N., Gerriets, V. A., Rathmell, J. C., Sharpe, A. H., et al. (2015) · Nature Immunology · doi:10.1038/ni.3077 · Cited by 412 · see citing works
The dichotomous nature of T helper 17 cells
Stockinger, B., & Omenetti, S. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.50 · Cited by 399 · see citing works
Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kiéda, C., Janji, B., & Chouaı̈b, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2015 · Cited by 405 · see citing works
Cytokines in Radiobiological Responses: A Review
Schaue, D., Kachikwu, E. L., & McBride, W. (2012) · Radiation Research · doi:10.1667/rr3031.1 · Cited by 372 · see citing works
Mitochondrial control of immunity: beyond ATP
Mehta, M., Weinberg, S. E., & Chandel, N. S. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.66 · Cited by 398 · see citing works
Jayaprakash, P., Ai, M., Liu, A., Budhani, P., Bartkowiak, T., Sheng, J., Ager, C., Nicholas, C., Jaiswal, A. R., Sun, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96268 · Cited by 399 · see citing works
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398 · see citing works
Disease tolerance and immunity in host protection against infection
Soares, M. P., Teixeira, L., & Moita, L. F. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2016.136 · Cited by 376 · see citing works
CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity
Wang, C., Yosef, N., Gaublomme, J. T., Wu, C., Lee, Y., Clish, C. B., Kaminski, J., Xiao, S., zu Hörste, G. M., Pawlak, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.068 · Cited by 387 · see citing works
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
Ohta, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00109 · Cited by 385 · see citing works
The plasticity of human Treg and Th17 cells and its role in autoimmunity
Kleinewietfeld, M., & Hafler, D. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.009 · Cited by 389 · see citing works
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
Pollizzi, K. N., & Powell, J. D. (2014) · Nature reviews. Immunology · doi:10.1038/nri3701 · Cited by 379 · see citing works
The ERK and JNK pathways in the regulation of metabolic reprogramming
Papa, S., Choy, P. M., & Bubici, C. (2018) · Oncogene · doi:10.1038/s41388-018-0582-8 · Cited by 381 · see citing works
Follicular helper T cells in immunity and systemic autoimmunity
Craft, J. E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.58 · Cited by 375 · see citing works
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 368 · see citing works
Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
Eltzschig, H. K., Bratton, D. L., & Colgan, S. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4422 · Cited by 363 · see citing works
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
Chouaı̈b, S., Noman, M. Z., Kosmatopoulos, K., & Curran, M. A. (2016) · Oncogene · doi:10.1038/onc.2016.225 · Cited by 366 · see citing works
Intricacies of TGF-β signaling in Treg and Th17 cell biology
Wang, J., Zhao, X., & Wan, Y. Y. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01036-7 · Cited by 377 · see citing works
NF ‐κB and HIF crosstalk in immune responses
D’Ignazio, L., Bandarra, D., & Rocha, S. (2015) · FEBS Journal · doi:10.1111/febs.13578 · Cited by 367 · see citing works
Liu, J., Zhang, X., Chen, K., Cheng, Y., Liu, S., Meng, X., Chen, Y., Zhu, H., Li, Z., & Cao, X. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.021 · Cited by 353 · see citing works
The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease
Yan, J., Luo, M., Chen, Z., & He, B. (2020) · Journal of Immunology Research · doi:10.1155/2020/8813558 · Cited by 344 · see citing works
- Authors
- Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., Luo, W., Zeller, K., Shimoda, L., Topalian, S. L., Semenza, G. L., Dang, C. V., Pardoll, D. M., & Pan, F.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Pardoll, Drew M.
- Pan, Fan
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 146
- Issue
- 5
- Pages
- 772-784
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3387678
- OpenAlex
- W2134053452
- Cited by
- 1,595
- References
- 49
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 107 · 2023: 117 · 2022: 133 · 2021: 136 · 2020: 130 · 2019: 106 · 2018: 100 · 2017: 107 · 2016: 107 · 2015: 97 · 2014: 88 · 2013: 84 · 2012: 81
- FWCI
- 36.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 685 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Alexander and Margaret Stewart Trust
- Melanoma Research Alliance
- Memorial Sloan-Kettering Cancer Center
- Johns Hopkins University
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI089830)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- HIF-1, HIF-1α, Th17 cells, regulatory T cells, T cell differentiation, RORγt, Foxp3, P300, proteasomal degradation, T cell metabolism, experimental autoimmune encephalitis, T cell fate determination
- MeSH terms
- Animals, Base Sequence, Encephalomyelitis, Autoimmune, Experimental, Humans, Molecular Sequence Data, Sequence Alignment, Jurkat Cells, Interleukin-17, T-Lymphocytes, Regulatory, STAT3 Transcription Factor, p300-CBP Transcription Factors, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit, Forkhead Transcription Factors, Nuclear Receptor Subfamily 1, Group F, Member 3, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review